Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Neoplasms | 2 | 2022 | 15 | 0.960 |
Why?
|
| Vascular Malformations | 1 | 2022 | 19 | 0.830 |
Why?
|
| Nose Neoplasms | 1 | 2017 | 25 | 0.580 |
Why?
|
| Rhinoplasty | 1 | 2017 | 27 | 0.570 |
Why?
|
| Hemangioma | 1 | 2017 | 51 | 0.570 |
Why?
|
| Mohs Surgery | 1 | 2004 | 16 | 0.240 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2004 | 40 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 446 | 0.190 |
Why?
|
| Societies, Medical | 1 | 2022 | 403 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 375 | 0.170 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2019 | 5 | 0.170 |
Why?
|
| Port-Wine Stain | 1 | 2019 | 7 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 629 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 250 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 223 | 0.150 |
Why?
|
| Lasers, Dye | 1 | 2017 | 4 | 0.150 |
Why?
|
| Injections, Intralesional | 1 | 2017 | 25 | 0.150 |
Why?
|
| Early Medical Intervention | 1 | 2017 | 16 | 0.150 |
Why?
|
| Propranolol | 1 | 2017 | 103 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 186 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 951 | 0.120 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 16 | 0.110 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 14 | 0.110 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 6 | 0.110 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 23 | 0.110 |
Why?
|
| Infant | 2 | 2017 | 2891 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 82 | 0.110 |
Why?
|
| Sirolimus | 1 | 2013 | 118 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 331 | 0.100 |
Why?
|
| Algorithms | 1 | 2017 | 1196 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2455 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 331 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2017 | 3187 | 0.090 |
Why?
|
| Child | 2 | 2017 | 6405 | 0.080 |
Why?
|
| Humans | 6 | 2022 | 68618 | 0.080 |
Why?
|
| Adolescent | 2 | 2017 | 8912 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 5717 | 0.070 |
Why?
|
| Adult | 3 | 2017 | 21403 | 0.070 |
Why?
|
| Sunlight | 1 | 2004 | 59 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2013 | 2689 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2014 | 294 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 334 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1851 | 0.040 |
Why?
|
| Laser Therapy | 1 | 2019 | 54 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 64 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 4848 | 0.030 |
Why?
|
| Animals | 3 | 2019 | 20881 | 0.030 |
Why?
|
| Aged | 2 | 2013 | 14862 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2013 | 111 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 304 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 8474 | 0.030 |
Why?
|
| Female | 3 | 2014 | 38074 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 852 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 307 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 2791 | 0.020 |
Why?
|
| Male | 2 | 2013 | 37321 | 0.020 |
Why?
|
| Middle Aged | 1 | 2004 | 21147 | 0.020 |
Why?
|